Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Gene silencing by the tRNA maturase tRNase ZL under the direction of small-guide RNA

Abstract

We have been developing a unique system for the downregulation of a gene expression through cutting a specific mRNA by the long form of tRNA 3′-processing endoribonuclease (tRNase ZL) under the direction of small-guide RNA (sgRNA). However, the efficacy of this system and the involvement of tRNase ZL in the living cells were not clear. Here we show, by targeting the exogenous luciferase gene, that the efficacy of the sgRNA/tRNase ZL method can become comparable to that of the RNA interference technology and that the gene silencing is owing to tRNase ZL directed by sgRNA not owing to a simple antisense effect. We also show that tRNase ZL together with sgRNA can downregulate expression of the endogenous human genes Bcl-2 and glycogen synthase kinase-3β by degrading their mRNAs in cell culture. Furthermore, we demonstrate that a gene expression in the livers of postnatal mice can be inhibited by an only seven-nucleotide sgRNA. These data suggest that sgRNA might be utilized as therapeutic agents to treat diseases such as cancers and AIDS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Mörl M, Marchfelder A . The final cut. The importance of tRNA 3′-processing. EMBO Rep 2001; 2: 17–20.

    Article  Google Scholar 

  2. Nashimoto M . Distribution of both lengths and 5′ terminal nucleotides of mammalian pre-tRNA 3′ trailers reflects properties of 3′ processing endoribonuclease. Nucleic Acids Res 1997; 25: 1148–1155.

    Article  CAS  Google Scholar 

  3. Schiffer S, Rosch S, Marchfelder A . Assigning a function to a conserved group of proteins: the tRNA 3′-processing enzymes. EMBO J 2002; 21: 2769–2777.

    Article  CAS  Google Scholar 

  4. Takaku H, Minagawa A, Masamichi T, Nashimoto M . A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoriobonuclease. Nucleic Acids Res 2003; 31: 2272–2278.

    Article  CAS  Google Scholar 

  5. Minagawa A, Takaku H, Takagi M, Nashimoto M . A novel endonucleolytic mechanism to generate the CCA 3′ termini of tRNA molecules in Thermotoga maritima. J Biol Chem 2004; 279: 15688–15697.

    Article  CAS  Google Scholar 

  6. Takaku H, Minagawa A, Takagi M, Nashimoto M . The N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activity. Nucleic Acids Res 2004; 32: 4429–4438.

    Article  CAS  Google Scholar 

  7. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001; 27: 172–180.

    Article  CAS  Google Scholar 

  8. Zareen N, Yan H, Hopkinson A, Levinger L . Residues in the conserved His domain of fruit fly tRNase Z that function in catalysis are not involved in substrate recognition or binding. J Mol Biol 2005; 350: 189–199.

    Article  CAS  Google Scholar 

  9. Nashimoto M . Conversion of mammalian tRNA 3′ processing endoribonuclease to four-base-recognizing RNA cutters. Nucleic Acids Res 1995; 23: 3642–3647.

    Article  CAS  Google Scholar 

  10. Nashimoto M . Specific cleavage of target RNAs from HIV-1 with 5′ half tRNA by mammalian tRNA 3′ processing endoribonuclease. RNA 1996; 2: 2523–2524.

    Google Scholar 

  11. Nashimoto M, Geary S, Tamura M, Kasper R . RNA heptamers that directs RNA cleavage by mammalian tRNA 3′ processing endoribonuclease. Nucleic Acids Res 1998; 26: 2565–2571.

    Article  CAS  Google Scholar 

  12. Nashimoto M . Anomalous RNA substrates for mammalian tRNA 3′ processing endoribonuclease. FEBS Lett 2000; 472: 179–186.

    Article  CAS  Google Scholar 

  13. Shibata HS, Takaku H, Takagi M, Nashimoto M . The T loop structure is dispensable for substrate recognition by tRNase ZL. J Biol Chem 2005; 280: 22326–22334.

    Article  CAS  Google Scholar 

  14. Takaku H, Minagawa A, Takagi M, Nashimoto M . A novel four-base-recognizing RNA cutter that can remove the single 3′ terminal nucleotides from RNA molecules. Nucleic Acids Res 2004; 32: e91.

    Article  Google Scholar 

  15. Tamura M, Nashimoto C, Miyake N, Daikuhara Y, Ochi K, Nashimoto M . Intracellular mRNA cleavage by 3′ tRNase under the direction of 2′-O-methyl RNA heptamers. Nucleic Acids Res 2003; 31: 4354–4360.

    Article  CAS  Google Scholar 

  16. HabuY, Miyano-Kurosaki N, Kitano M, Endo Y, Yukita M, Ohira S et al. Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res 2005; 33: 235–243.

    Article  Google Scholar 

  17. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498.

    Article  CAS  Google Scholar 

  18. Hu W, Kavanagh JJ . Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003; 4: 721–729.

    Article  CAS  Google Scholar 

  19. Nelson WJ, Nusse R . Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004; 303: 1483–1487.

    Article  CAS  Google Scholar 

  20. Liu F, Song Y, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.

    Article  CAS  Google Scholar 

  21. McManus MT, Sharp PA . Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737–747.

    Article  CAS  Google Scholar 

  22. Appasani K . RNA Interference Technology: from Basic Science to Drug Development. Cambridge University Press: Cambridge, 2005.

    Book  Google Scholar 

  23. Cui J, Zhou X, LiuY, Tang Z, Romeih M . Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. J Gastroenterol Hepatol 2003; 18: 280–287.

    Article  CAS  Google Scholar 

  24. Zhang G, Budker V, Wolff JA . High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735–1737.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr M Abe for creating stable transfectants. This work was supported in part by the Science Research Promotion Fund and the Academic Frontier Research Project Grant from the Promotion and Mutual Aid Corporation for Private Schools of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Nashimoto.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakashima, A., Takaku, H., Shibata, H. et al. Gene silencing by the tRNA maturase tRNase ZL under the direction of small-guide RNA. Gene Ther 14, 78–85 (2007). https://doi.org/10.1038/sj.gt.3302841

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302841

Keywords

This article is cited by

Search

Quick links